Metabolic memory in diabetes - focus on insulin

被引:71
作者
LeRoith, D
Fonseca, V
Vinik, A
机构
[1] Georgetown Univ, Sch Med, Washington, DC 20057 USA
[2] Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70118 USA
[3] Eastern Virginia Med Sch, Diabet Res Inst, Norfolk, VA 23501 USA
关键词
insulin; metabolic memory; diabetes; microvascular complications; macrovascular complications; anti-inflammatory;
D O I
10.1002/dmrr.530
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Large-scale clinical trials have demonstrated that metabolic control achieved early in the course of diabetes substantially reduces development and progression of diabetes and the associated microvascular complications. Additionally, prospective observational studies have demonstrated that atherogenic and inflammatory mediators are elevated even prior to the onset of diabetes and significantly contribute to subsequent development of macrovascular complications. Collectively, these data suggest that metabolic memories are stored early in the course of diabetes. We believe that insulin suppresses inflammation and also suppresses glucotoxicity and lipotoxicity (and the consequences thereof, such as the formation of advanced glycation end products and epigenetic phenomena), and thus has a pivotal and beneficial role. Comprehensive metabolic control, especially when instituted early, may alter the natural history of diabetic complications by affecting this metabolic memory. Thus, our overall goal is to understand in more detail the molecular mechanisms involved in these changes, thereby affording us opportunities to reduce the long-term effects of diabetes. Copyright (c) 2005 John Wiley & Sons, Ltd.
引用
收藏
页码:85 / 90
页数:6
相关论文
共 43 条
[21]   Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function [J].
McFarlane, SI ;
Chaiken, RL ;
Hirsch, S ;
Harrington, P ;
Lebovitz, HE ;
Banerji, MA .
DIABETIC MEDICINE, 2001, 18 (01) :10-16
[22]   Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus [J].
Meigs, JB ;
Hu, FB ;
Rifai, N ;
Manson, JE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (16) :1978-1986
[23]   Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance - The Framingham Offspring Study [J].
Meigs, JB ;
Nathan, DM ;
Wilson, PWF ;
Cupples, LA ;
Singer, DE .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (07) :524-+
[24]   Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells [J].
Montagnani, M ;
Golovchenko, I ;
Kim, I ;
Koh, GY ;
Goalstone, ML ;
Mundhekar, AN ;
Johansen, M ;
Kucik, DF ;
Quon, MJ ;
Draznin, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (03) :1794-1799
[25]  
Nathan DM, 2003, NEW ENGL J MED, V348, P761
[26]   The missing link: A single unifying mechanism for diabetic complications [J].
Nishikawa, T ;
Edelstein, D ;
Brownlee, M .
KIDNEY INTERNATIONAL, 2000, 58 :S26-S30
[27]   The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients [J].
Nomiyama, T ;
Tanaka, Y ;
Piao, L ;
Nagasaka, K ;
Sakai, K ;
Ogihara, T ;
Nakajima, K ;
Watada, H ;
Kawamori, R .
JOURNAL OF HUMAN GENETICS, 2003, 48 (03) :138-141
[28]   Metabolic programming: Causes and consequences [J].
Patel, MS ;
Srinivasan, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (03) :1629-1632
[29]   Cellular mechanism of insulin resistance: potential links with inflammation [J].
Perseghin, G ;
Petersen, K ;
Shulman, GI .
INTERNATIONAL JOURNAL OF OBESITY, 2003, 27 (Suppl 3) :S6-S11
[30]   C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus [J].
Pradhan, AD ;
Manson, JE ;
Rifai, N ;
Buring, JE ;
Ridker, PM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (03) :327-334